Abbott links with German firm for antibody drug Chicago Sun-Times ABBOTT PARK — Abbott Laboratories has entered into type A global agreement with type A German firm to develop a new antibody to treat rheumatoid arthritis and psoriasis . Abbott and Biotest AG announced they will commercialize the antibody BT-061, ... Link To Article
No comments:
Post a Comment